Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Scientific Reports|July 2, 2025
Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathyUsua Oyarbide, Rebecca A Anderson, Igor Radzikh, et al.
Research Square|May 2, 2025
Tafazzin-Deficient Zebrafish Display Mitochondrial Dysfunction, Neutropenia, and Metabolic Defects Without MyopathyUsua Oyarbide, Rebecca A Anderson, Igor Radzikh, et al.
Biochemistry|January 12, 2005
Assembly of human frataxin is a mechanism for detoxifying redox-active ironHeather A O'Neill, Oleksandr Gakh, Sungjo Park, et al.
Plos One|April 27, 2010
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesGuy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of soft tissue sarcomaGonzalo Lopez, Juehui Liu, Wenhong Ren, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2026
Hog1/p38 and ZAKα drive Shwachman-Diamond syndrome and provide targets to improve cell growthNozomu Kawashima, Neha Prasad, Frank Tedeschi, et al.
Journal of Cellular and Molecular Medicine|July 5, 2018
Captopril mitigates splenomegaly and myelofibrosis in the Gata1low murine model of myelofibrosisSeth J Corey, Jyoti Jha, Elizabeth A McCart, et al.
Journal of Cell Science|June 11, 2009
The F-BAR protein CIP4 promotes GLUT4 endocytosis through bidirectional interactions with N-WASp and Dynamin-2Sean M Hartig, Shuhei Ishikura, Rachel S Hicklen, et al.
Molecular Cancer Therapeutics|May 22, 2007
Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulationJonathan A F Hannay, Juehui Liu, Quan-Sheng Zhu, et al.
Blood Advances|December 13, 2018
Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activityPraveen K Suraneni, Seth J Corey, Michael J Hession, et al.
Pageof 11